These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 28573077)

  • 21. Clustered Regularly Interspaced Short Palindromic Repeats System of Genome Engineering in Embryos to Repair Genes.
    Niazvand F; Fathinezhad Z; Alfuraiji N; Etajuri EA; Amini-Chermahini F; Chehelgerdi M; Ranjbar R
    J Biomed Nanotechnol; 2021 Mar; 17(3):331-356. PubMed ID: 33875070
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Computational Tools and Resources for CRISPR/Cas Genome Editing.
    Li C; Chu W; Gill RA; Sang S; Shi Y; Hu X; Yang Y; Zaman QU; Zhang B
    Genomics Proteomics Bioinformatics; 2023 Feb; 21(1):108-126. PubMed ID: 35341983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [CRISPR/Cas-based genome editing in Aspergillus niger].
    Zheng X; Zheng P; Sun J
    Sheng Wu Gong Cheng Xue Bao; 2021 Mar; 37(3):980-990. PubMed ID: 33783162
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The new CRISPR-Cas system: RNA-guided genome engineering to efficiently produce any desired genetic alteration in animals.
    Seruggia D; Montoliu L
    Transgenic Res; 2014 Oct; 23(5):707-16. PubMed ID: 25092533
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genome Surgery and Gene Therapy in Retinal Disorders.
    Chan L; Mahajan VB; Tsang SH
    Yale J Biol Med; 2017 Dec; 90(4):523-532. PubMed ID: 29259518
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emergent CRISPR-Cas-based technologies for engineering non-model bacteria.
    Volke DC; Orsi E; Nikel PI
    Curr Opin Microbiol; 2023 Oct; 75():102353. PubMed ID: 37413959
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Applications of Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) as a Genetic Scalpel for the Treatment of Cancer: A Translational Narrative Review.
    Mondal R; Brahmbhatt N; Sandhu SK; Shah H; Vashi M; Gandhi SK; Patel P
    Cureus; 2023 Dec; 15(12):e50031. PubMed ID: 38186450
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Applications of CRISPR Genome Engineering in Cell Biology.
    Wang F; Qi LS
    Trends Cell Biol; 2016 Nov; 26(11):875-888. PubMed ID: 27599850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Applications of CRISPR systems in respiratory health: Entering a new 'red pen' era in genome editing.
    Moses C; Kaur P
    Respirology; 2019 Jul; 24(7):628-637. PubMed ID: 30883991
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CRISPR/Cas system: An emerging technology in stem cell research.
    Valenti MT; Serena M; Carbonare LD; Zipeto D
    World J Stem Cells; 2019 Nov; 11(11):937-956. PubMed ID: 31768221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A CRISPR-Assisted Nonhomologous End-Joining Strategy for Efficient Genome Editing in Mycobacterium tuberculosis.
    Yan MY; Li SS; Ding XY; Guo XP; Jin Q; Sun YC
    mBio; 2020 Jan; 11(1):. PubMed ID: 31992616
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enabling Precision Medicine with CRISPR-Cas Genome Editing Technology: A Translational Perspective.
    Ilahibaks NF; Hulsbos MJ; Lei Z; Vader P; Sluijter JPG
    Adv Exp Med Biol; 2023; 1396():315-339. PubMed ID: 36454475
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CRISPR/Cas Genome Editing and Precision Plant Breeding in Agriculture.
    Chen K; Wang Y; Zhang R; Zhang H; Gao C
    Annu Rev Plant Biol; 2019 Apr; 70():667-697. PubMed ID: 30835493
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plant Viruses: From Targets to Tools for CRISPR.
    Varanda CM; Félix MDR; Campos MD; Patanita M; Materatski P
    Viruses; 2021 Jan; 13(1):. PubMed ID: 33478128
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nanocarriers: A novel strategy for the delivery of CRISPR/Cas systems.
    Hejabi F; Abbaszadeh MS; Taji S; O'Neill A; Farjadian F; Doroudian M
    Front Chem; 2022; 10():957572. PubMed ID: 36092658
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CRISPR/Cas-based tools for the targeted control of plant viruses.
    Robertson G; Burger J; Campa M
    Mol Plant Pathol; 2022 Nov; 23(11):1701-1718. PubMed ID: 35920132
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Progress and challenges towards CRISPR/Cas clinical translation.
    Rosenblum D; Gutkin A; Dammes N; Peer D
    Adv Drug Deliv Rev; 2020; 154-155():176-186. PubMed ID: 32659256
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent advances in structural studies of the CRISPR-Cas-mediated genome editing tools.
    Zhu Y; Huang Z
    Natl Sci Rev; 2019 May; 6(3):438-451. PubMed ID: 34691893
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CRISPR-Cas systems: ushering in the new genome editing era.
    Perez Rojo F; Nyman RKM; Johnson AAT; Navarro MP; Ryan MH; Erskine W; Kaur P
    Bioengineered; 2018; 9(1):214-221. PubMed ID: 29968520
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CRISPR based therapeutics: a new paradigm in cancer precision medicine.
    Das S; Bano S; Kapse P; Kundu GC
    Mol Cancer; 2022 Mar; 21(1):85. PubMed ID: 35337340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.